Overview

Broad business vision. Vide experience in Multiple content worlds. My specialization stems from over 30 years of practical experience as a serial entrepreneur and small business consultant. M.B.A from Tel Aviv University. Engaged in endurance extreme sports.

Founder and CEO of Lasting Effect Consumer Pharma, founded in 2020. Lasting Effect developing products based on its novel technology of Buccal Adhesive Extended Release Drug Delivery System enable loading a wide range of API`s for topical and systemic absorption of up to 8 hours, during day and sleep time usage. Lasting Effect disruptive technology solves the technical and user experience problems that prevented from buccal extended release products to be excepted by the pharma market.

Lasting Effect has a ready to market product for the treatment of Xerostomia (dry mouth), made two successful patient assessments. The product is in an assessment phase by global dental distributor.

Product with CBD for Gingivitis treatment, in clinical trial in Israel. The clinical trial done by MaccabiDent, an investor in the company.

Product for the treatment of late motor complications of Parkinson patient, aimed for substituting invasive devices like DBS and AbbVie's Duopa pump. The product in development stage, CTO of the project is prof. Eli Heldman (the founder and developer of Neuroderm, sold to Tanabe Pharma for $1.1 B). Initial investment done by Ariel Malik (CTW) and Kobi Zecharia.

Lasting Effect is looking for investment for the repurposing of a known API for the treatment of sleep disorders of PTSD patients, a joint project with the Beer Sheva mental health hospital and its manager prof. Doron Todar.